Stock Earnings

Question 1

Mersana Therapeutics Inc'in temel mali tabloları nelerdir?

Accepted Answer

Son mali tabloya (Form-10K) göre, Mersana Therapeutics Inc'in toplam varlıkları $144 olup, net loss $-69'dir.

Question 2

MRSN'ün temel finansal oranları nelerdir?

Accepted Answer

Mersana Therapeutics Inc'in cari oranı 0.93, net kâr marjı -172.5, hisse başına satış $8.16'dir.

Question 3

Mersana Therapeutics Inc'in geliri segment veya coğrafya bazında nasıl dağılıyor?

Accepted Answer

Mersana Therapeutics Inc largest revenue segment is Antibody-drug Conjugates, at a revenue of 40,497,000 in the most earnings release.For geography, United States is the primary market for Mersana Therapeutics Inc, at a revenue of 40,497,000.

Question 4

Mersana Therapeutics Inc kârlı mı?

Accepted Answer

no, son mali tablolara göre Mersana Therapeutics Inc'in net loss $-69'dir.

Question 5

Mersana Therapeutics Inc'in herhangi bir yükümlülüğü var mı?

Accepted Answer

yes, Mersana Therapeutics Inc'in yükümlülüğü 154'dir.

Question 6

Mersana Therapeutics Inc'in tedavüldeki hisse sayısı kaçtır?

Accepted Answer

Mersana Therapeutics Inc'in toplam tedavüldeki hisse sayısı 4.62'dir.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	34	40	36	26	0	0
Revenue Growth (YoY)	17%	11%	38%	--	--	-100%
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	35	40	59	56	36	21
Research & Development	71	73	148	173	132	67
Operating Expenses	106	113	207	230	168	88
Other Non Operating Income (Expenses)	--	--	--	--	--	--
Pretax Income	-73	-68	-171	-204	-170	-88
Income Tax Expense	--	0	--	--	--	--
Net Income	-74	-69	-171	-204	-170	-88
Net Income Growth	-28.99%	-60%	-16%	20%	93%	214%
Shares Outstanding (Diluted)	4.98	4.9	4.64	3.74	2.82	2.45
Shares Change (YoY)	2%	6%	24%	33%	15%	41%
EPS (Diluted)	-14.84	-14.11	-36.96	-54.51	-60.23	-35.8
EPS Growth	-31%	-62%	-32%	-10%	68%	121%
Free Cash Flow	-79	-82	-171	-51	-140	-75
Free Cash Flow Per Share	-15.84	-16.72	-36.81	-13.61	-49.58	-30.49
Gross Margin	--	--	--	--	--	--
Operating Margin	-208.82%	-182.5%	-472.22%	-780.76%	0%	0%
Profit Margin	-217.64%	-172.5%	-475%	-784.61%	0%	0%
Free Cash Flow Margin	-232.35%	-204.99%	-475%	-196.15%	0%	0%
EBITDA	-70	-72	-169	-203	-168	-87
EBITDA Margin	-205.88%	-180%	-469.44%	-780.76%	0%	0%
D&A For EBITDA	1	1	1	0	0	1
EBIT	-71	-73	-170	-203	-168	-88
EBIT Margin	-208.82%	-182.5%	-472.22%	-780.76%	0%	0%
Effective Tax Rate	--	0%	--	--	--	--

Mersana Therapeutics Inc (MRSN) Price

MRSN Stock Price Chart

MRSN Income

Follow-Up Questions